SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 270.83 |
Enterprise Value ($M) | 98.27 |
Book Value ($M) | 493.40 |
Book Value / Share | 5.56 |
Price / Book | 0.55 |
NCAV ($M) | 388.76 |
NCAV / Share | 4.38 |
Price / NCAV | 0.70 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.35 |
Return on Assets (ROA) | -0.27 |
Return on Equity (ROE) | -0.34 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 12.65 |
Current Ratio | 12.65 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 542.75 |
Assets | 647.39 |
Liabilities | 153.99 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 32.33 |
Operating Income | -228.66 |
Net Income | -198.71 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -157.69 |
Cash from Investing | 74.88 |
Cash from Financing | 49.20 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | State Street Corp | 3.80 | -23.92 | |
13G/A | Millennium Management Llc | 4.60 | -26.95 | |
13G/A | ARK Investment Management LLC | 0.00 | -100.00 | |
13G | Biotechnology Value Fund L P | 8.20 | ||
13G/A | Vanguard Group Inc | 4.73 | 0.00 | |
13G/A | BlackRock, Inc. | 8.60 | 0.00 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
358,976 | 2,165,215 | 16.58 | |
283,735 | 1,763,076 | 16.09 | |
521,958 | 3,460,345 | 15.08 | |
534,971 | 2,155,541 | 24.82 | |
598,400 | 3,048,865 | 19.63 | |
(click for more detail) |
Similar Companies | |
---|---|
TYRA – Tyra Biosciences, Inc. | UBX – Unity Biotechnology, Inc. |
UTHR – United Therapeutics Corporation | VIGL – Vigil Neuroscience, Inc. |
VIR – Vir Biotechnology, Inc. |
Financial data and stock pages provided by
Fintel.io